IRI Separation Technologies Inc.-Changes to the Board of Directors

IRI Separation Technologies Inc. (TSX VENTURE:IRI) announces the following
changes to its Board of Directors.


At the Company's AGM held on the 31st July, the following directors were
re-appointed for the ensuing year: Wayne Christensen, Carol Leacy and John
Mason. 


The following new Directors were appointed, Michael Hoole, Dr. Bryan Simmons and
Bryan Tassin, to comprise a board of six directors.


Subsequent to the AGM, resignations have been received from Wayne Christensen,
Carol Leacy and Michael Hoole.


The remaining Directors have, in accordance with the provisions of the Company's
Articles, filled the vacancies with Ronald Bayne, Paul Frigstad and David Mason
- the replacement Directors have considerable experience in the Company's
affairs and the development of Specific Antibodies and have filed their consent
to act at the Company's registered offices.


About IRI Separation Technologies Inc.

IRI Separation Technologies Inc. (TSX VENTURE:IRI) is a biotechnology company
that specializes in the extraction, development and commercialization of
polyclonal immunoglobulin antibodies for virus and bacteria related health
issues. Intended for use as a nutraceutical for human consumption, the
antibodies are derived from chicken eggs. The immunoglobulin antibodies are
intended for both the general and specific antibody market.

IEMR Resources (TSXV:IRI)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024